The Japan medical robots market was valued at USD 733.25 Million in 2025 and is expected to grow at a CAGR of 15.80%, reaching USD 3179.35 Million by 2035. The market growth is driven by the rising healthcare automation, aging population, and demand for minimally invasive surgeries across the region.
Base Year
Historical Period
Forecast Period
Olympus’s USD 65 million investment in Swan EndoSurgical will likely accelerate robotic innovation, boosting Japan’s dominance in advanced surgical and hospital robotic systems.
Tele-surgery breakthroughs using the hinotori™ robot will expand access to specialized surgical care, driving faster adoption of robotic technologies nationwide.
Japan Activation Capital’s stake in Omron reflects strong investor confidence, signaling sustained funding growth for Japan’s medical robotics ecosystem.
Compound Annual Growth Rate
15.8%
Value in USD Million
2026-2035
*this image is indicative*
The market is growing rapidly due to rising demand for minimally invasive surgeries, an aging population, and advancements in robotics technology. Government initiatives supporting healthcare automation, coupled with increased hospital investments in surgical robots and rehabilitation systems, are driving adoption. Japan’s strong manufacturing capabilities and collaborations between technology firms and medical institutions enhance product innovation. With expanding applications in surgery, diagnostics, and patient care, the market in Japan is poised for significant growth opportunities.
Strategic Investments Driving Market Growth
In July 2025, Olympus invested USD 65 million in Swan EndoSurgical to develop advanced endoluminal gastrointestinal robotics. This strategic move aims to expand Japan’s medical robotics ecosystem, fueling innovation and enhancing treatment precision. Such investments significantly drive the market growth, positioning the country as a hub for robotic healthcare technologies while strengthening its global competitiveness in surgical and hospital robotic systems.
Key market trends include tele-surgery breakthroughs and rising investor confidence in healthcare automation.
Remote Surgery Advancements Accelerating Market Development in Japan
In June 2025, Medicaroid, NTT Communications, and the Japan Surgical Society successfully conducted a remote surgery demonstration using the hinotori™ surgical robot system between Strasbourg and Kobe. This breakthrough in tele-surgery highlights Japan’s leadership in integrating high-speed communication with robotics, accelerating market development by enabling wider access to advanced surgical procedures, and addressing healthcare workforce challenges in remote regions.
Increasing Investments to Strengthen Japan Medical Robots Market Value
In July 2025, Japan Activation Capital (JAC) acquired a 4% stake in Omron for USD 210 million, signaling strong investor confidence in Japan’s robotics and healthcare technology sectors. This acquisition underlines the rising market value of Japanese robotics companies and aligns with the government’s focus on healthcare automation, expanding funding opportunities for medical robot development, and accelerating commercial adoption across multiple clinical settings.
Hospital and Pharmacy Robotic Systems to Lead the Segmentation by Type
The market has witnessed steady growth, with hospital and pharmacy robotic systems emerging as the dominant segment, capturing a 20% revenue share in the historical period. This leadership is driven by rising demand for automation in hospitals, growing focus on infection control, and the need for efficient pharmaceutical handling solutions. Additionally, Japan’s strong technological infrastructure and government support for healthcare modernization further accelerate the adoption of medical robotics, positioning the country as a key player in the Asia-Pacific region.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Intuitive Surgical, Inc., founded in 1995, is headquartered in Sunnyvale, California, USA. The company designs, manufactures, and markets robotic-assisted surgical systems, most notably the da Vinci Surgical System, as well as the Ion system for minimally invasive lung biopsies. Its portfolio includes multiport, single-port, imaging-enhanced, and console-based robotics for general, urologic, gynecologic, thoracic, and other surgical disciplines. For instance, in July 2025, Intuitive’s da Vinci 5 Surgical System received CE Mark approval in Europe, featuring over 150 enhancements, including force feedback and improved 3D vision.
Stryker Corporation, established in 1941 by Dr. Homer Stryker, is based in Kalamazoo, Michigan, USA. It is a major medical technology firm with a broad portfolio spanning orthopedic implants (hip, knee, trauma), instruments and surgical equipment, neurotechnology & spine, endoscopy, and patient handling/emergency medical equipment. Over decades it has expanded through innovation and acquisitions (e.g., surgical navigation, minimally invasive systems) to serve multiple medical specialties globally.
Becton, Dickinson and Company (BD), founded in 1897, is headquartered in Franklin Lakes, New Jersey, USA. BD is a global medical technology company with three main segments: BD Medical (devices like syringes, infusion systems), BD Diagnostics, and BD Biosciences (reagents, lab instrumentation). The company supports hospitals, laboratories, and researchers, especially in areas like drug delivery, infection prevention, diagnostic testing. Recently, in July 2025, BD’s Biosciences & Diagnostic Solutions business agreed to merge with Waters Corporation in a 17.5 billion Reverse Morris Trust deal to deepen diagnostic and lab & life-science tools capabilities.
Medtronic PLC traces its foundations to and is headquartered in Dublin, Ireland (corporate HQ) and Minneapolis, Minnesota, for many operational units. It is one of the largest medical technology companies globally. Medtronic’s product offerings cover cardiac devices (pacemakers, heart valves, stents), diabetes management systems, surgical tools & robotics, spinal & neuromodulation implants, patient monitoring, and beyond. As a recent example, in April 2025, it submitted its Hugo robotic-assisted surgery system to the FDA for a urology indication after a clinical study met safety and effectiveness endpoints.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Smith + Nephew, Omnicell, Inc., Asensus Surgical, Inc., and Zimmer Biomet.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Application
Market Breakup by Mobility
Market Breakup by End User
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by Mobility |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share